6-Benzyloxyamino-4-chloro-2,5-diformamidopyrimidine → 9-Benzyloxy-6-chloro-2-formamidopurine

HRID 1165549

반응식

HRID 1165549 반응식
[CH2:1]([O:8][NH:9][C:10]1[N:15]=[C:14]([NH:16][CH:17]=[O:18])[N:13]=[C:12]([Cl:19])[C:11]=1[NH:20][CH:21]=O)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1>C(OC(OCC)OCC)(=O)C>[CH2:1]([O:8][N:9]1[CH:21]=[N:20][C:11]2[C:10]1=[N:15][C:14]([NH:16][CH:17]=[O:18])=[N:13][C:12]=2[Cl:19])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

참가 물질

3

반응물 1

HCID 145239606-Benzyloxyamino-4-chloro-2,5-diformamidopyrimidine

생성물 1

HCID 145239619-Benzyloxy-6-chloro-2-formamidopurine수율 62%

시약·촉매·용매 1

HCID 84166Methanol, 1,1-diethoxy-, 1-acetate용매

반응 조건

온도
20 °C

실험 절차

6-Benzyloxyamino-4-chloro-2,5-diformamidopyrimidine (1.2 g, 3.73 mmol) and diethoxymethyl acetate (20 ml) was stirred at 120° C. for 2.5 hours, cooled and evaporated under reduced pressure. The residue in methanol (20 ml) and concentrated ammonia solution (2 ml) was stirred at 20° C. for 1 hour, the solvent removed under reduced pressure and the residue co-evaporated with methanol. Column chromatography on silica gel (eluted with chloroform-ethanol, 100:1) afforded the title compound (700 mg, 62%). IR: νmax (KBr) 3119, 1702, 1611, 1577, 1505, 1440 cm-1 ; 1H NMR: δH [(CD3)2SO], 5.44 (2H, s, CH2Ph), 7.45 (5H, m, Ph), 8.54 (1H, s, H-8), 9.34 (1H, s, CHO), 11.30 (1H, br.s, D2O exchangeable, NH).

후처리

  1. temperaturecooled
  2. customevaporated under reduced pressure
  3. customthe solvent removed under reduced pressure

출처 및 근거

ORD 기록
ord-14760394e5714d76bba87d8cc5ca0598
출처 데이터셋
uspto-grants-1990_03
특허 번호
US04910307

연결된 노트

불러오는 중…